EULAR Task Forces 

It is EULAR's objective to promote task forces aimed at elaborating recommendations in the field of rheumatology with adherence to the principles of equality, diversity and inclusion.

The members of EULAR task forces are experienced investigators in Rheumatology with areas of focus such as Quality of Care and Clinical Affairs (QoC), Research (RES), Health Professionals in Rheumatology (HPR), and PARE People with Arthritis and Rheumatism (PARE).

Each task force is connected to and supported by a EULAR Committee. Each committee is entitled to apply for EULAR endorsement, and also apply for EULAR task force members (see related information).

To apply as task force member please go to the project dedicated application’s link below:


Open initiatives

EULAR wide general application call for 5 additional slots in the recently funded TF projects:

RES005- De Wit:  Updating the EULAR recommendations for the collaboration between researchers and patient research partners in scientific RMD projects

Link to RES005 application

 

QoC015-: Dimitrios Boumpas: Update of the EULAR recommendations for the Management of SLE

Link to QoC015 application

 

QoC016- J. Smolen:  2023 Update of the EULAR Recommendations for the management of psoriatic arthritis with pharmacological therapies

Link to QoC016 application

 

Please read the information related 3.1 Task force composition in the  EULAR SOPs.

Kindly note that once you submit the online application, you will receive a message on your screen of a successful submission. You will not receive any other confirmation of submission.

Deadline to apply: 10 November 23.45 hrs

See ongoing initiatives

 

Related Information
Application for Project Grants

EULAR welcomes project applications from rheumatologists across Europe designed for developing EULAR Recommendations, EULAR Criteria, EULAR Points to Consider, or similar projects.

See more


EULAR Recommendations

The EULAR Committees regularly establish and publish recommendations for the treatment of various rheumatic disorders. Each of these recommendations are developed by a Task Force of specialists in their field.

See more